English
Arabic
Chinese (Simplified)
Dutch
Esperanto
French
German
Greek
Italian
Japanese
Korean
Portuguese
Russian
Spanish
Urdu
The Mount Sinai researchers found that inpatients with heroin use disorder exhibited a bias in favor of processing drug cues over cues related to natural, non-drug rewards, as observed during passive viewing of the cues and when the patients were asked to try two emotional regulation strategies. Results of the study were published in the July 12 issue of the American Journal of Psychiatry.
For this study, researchers used functional magnetic resonance imaging (fMRI), an imaging scan that shows activity in a specific area of the brain, to track blood oxygenation in real time while individuals looked at drug-related, neutral, and food images. Since brain cells use more oxygen when active, the fMRI signals areas of the brain that “light up” when most active.
The research team found that in individuals with heroin use disorder, responses to drug cues (images of individuals using or simulating use of drugs or of drug paraphernalia) were enhanced in brain regions associated with reward and inhibitory control, while these individuals’ brain regions were less reactive to food or neutral images (e.g., stapler) when compared to healthy control subjects.
Although there were no group differences during the two emotional regulation strategies (aimed at decreasing drug-related reactions and enhancing natural reward-related reactions) when inspected separately, significant differences between the groups emerged when the two strategies were considered together. One of the emotional regulation strategies—cognitive reappraisal—involved re-evaluating the significance of the drug cues (e.g., imagining that the drugs in the pictures are not real, or that the people in the images are actors). The other emotional regulation strategy—savoring—involved enhancing the significance of the food cues (e.g., imagining holding, eating, and enjoying the food pictured).
Compared to healthy controls, participants with heroin use disorder showed enhanced cortico-striatal reactivity when reappraising drug cues compared to when savoring food cues, with healthy controls showing the opposite pattern.
“In heroin addiction, the effort to downregulate response to drug cues via reappraisal may come at the expense of the ability to upregulate healthy hedonic responses, depleting the cognitive-affective resources needed to enjoy natural, nondrug rewards,” said Yuefeng Huang, PhD, a postdoctoral fellow in psychiatry at the Icahn School of Medicine at Mount Sinai and first author of the study.
These findings suggest that inpatients who are in the early stage of treatment for heroin-use disorder possess the neural resources to modulate their emotional responses to drug and food cues. However, in these individuals the neural resources needed to suppress responses to drug cues appear to come at the cost of the ability to amplify responses to healthy reward stimuli, which may diminish the resources necessary to derive enjoyment from natural, non-drug rewards. Conversely, healthy controls who do not have addiction demonstrated the opposite pattern, pinpointing an important target for intervention to normalize function.
“This study paves the way for testing interventions to normalize these deficits, reduce craving, and enhance recovery in drug addiction, including via cognitive reappraisal and savoring in mindfulness-oriented recovery enhancement, non-invasive brain stimulation, and/or pharmacologically,” adds Rita Z. Goldstein, PhD, senior author of the study and Professor in Neuroimaging of Addiction at the Icahn School of Medicine at Mount Sinai.
The study team is currently collecting longitudinal data from the participants of the study who were scanned again after 15 weeks of treatment to investigate potential recovery effects. They are also planning to increase the recruitment of women to investigate sex differences in the patterns identified in the study, since the current sample size was small and predominantly men.
About the Mount Sinai Health System
Mount Sinai Health System is one of the largest academic medical systems in the New York metro area, with more than 43,000 employees working across eight hospitals, over 400 outpatient practices, nearly 300 labs, a school of nursing, and a leading school of medicine and graduate education. Mount Sinai advanced health for all people, everywhere, by taking on the most complex health care challenges of our time — discovering and applying new scientific learning and knowledge; developing safer, more effective treatments; educating the next generation of medical leaders and innovators; and supporting local communities by delivering high-quality care to all who need it.
Through the integration of its hospitals, labs, and schools, Mount Sinai offers comprehensive health care solutions from birth through geriatrics, leveraging innovative approaches such as artificial intelligence and informatics while keeping patients’ medical and emotional needs at the center of all treatment. The Health System includes approximately 7,300 primary and specialty care physicians; 13 joint-venture outpatient surgery centers throughout the five boroughs of New York City, Westchester, Long Island, and Florida; and more than 30 affiliated community health centers. We are consistently ranked by U.S. News & World Report‘s Best Hospitals, receiving high “Honor Roll” status, and are highly ranked: No. 1 in Geriatrics and top 20 in Cardiology/Heart Surgery, Diabetes/Endocrinology, Gastroenterology/GI Surgery, Neurology/Neurosurgery, Orthopedics, Pulmonology/Lung Surgery, Rehabilitation, and Urology. New York Eye and Ear Infirmary of Mount Sinai is ranked No. 12 in Ophthalmology. U.S. News & World Report’s “Best Children’s Hospitals” ranks Mount Sinai Kravis Children’s Hospital among the country’s best in several pediatric specialties.
For more information, visit https://www.mountsinai.org or find Mount Sinai on Facebook, Twitter and YouTube.
###
